Clinical Trials Logo

Clinical Trial Summary

This study is a randomized, double-blind, placebo-controlled study. It will assess the safety, tolerability, and pharmacokinetics of orally administered single and multiple doses of EDP-297 in healthy adult subjects.

Clinical Trial Description

The first phase assesses single ascending doses of EDP-297 or placebo in healthy subjects. A "fasted" and "fed" two-part cohort will also assess food effect. The second phase assesses multiple ascending doses of EDP-297 or placebo for 14-days in healthy subjects. Each cohort within each phase will enroll a total of 8 subjects who will be randomized to receive EDP-297 or placebo. The cohort assessing food effect will enroll 10 subjects randomized to receive EDP-297 or placebo ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04559126
Study type Interventional
Source Enanta Pharmaceuticals
Status Completed
Phase Phase 1
Start date September 8, 2020
Completion date June 21, 2021